Endo-Pro-Icatibant - Request Quote
Endo-Pro-Icatibant
| SZ CAT No: | SZ-I030040 |
| CAS No | NA |
| Mol.F. | C64H96N20O14S |
| Mol.Wt. | 1401.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Endo-Pro-Icatibant is chemically ((2S,3aS,7aS)-1-((R)-2-(((S)-2-(2-((2R,4S)-1-(D-arginyl-L-arginyl-D-prolyl-D-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanoyl)-L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine. Endo-Pro-Icatibant is supplied with detailed characterization data compliant with regulatory guideline. Endo-Pro-Icatibant can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Icatibant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Endo-Pro-Icatibant
Purchase Endo-Pro-Icatibant
Endo-Pro-Icatibant suppliers
Endo-Pro-Icatibant manufacturers
Endo-Pro-Icatibant price
Order Endo-Pro-Icatibant
Enquire Endo-Pro-Icatibant
Endo-Pro-Icatibant cost
Endo-Pro-Icatibant Supplier
Endo-Pro-Icatibant Distributor
Endo-Pro-Icatibant for Method Validation
Icatibant Reference Standard
Endo-Pro-Icatibant for ANDA Filing
Endo-Pro-Icatibant for Forced Degradation Studies
Endo-Pro-Icatibant Identification Standards
Endo-Pro-Icatibant for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


